Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT06058988
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
30
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Brain Cancer
Glioblastoma
Metastatic Cancer
Leptomeningeal Metastasis
Recurrent Glioblastoma
RECRUITING
NCT05376878
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
10
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma
Metastatic Malignant Neoplasm in the Brain
ACTIVE_NOT_RECRUITING
NCT05113251
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
927
Enrollment(s)
146
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Neoplasms
Breast Cancer
HER2-positive Early Breast Cancer
RECRUITING
NCT04379596
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
450
Enrollment(s)
100
Study location(s)
INTERVENTIONAL (PHASE2)
Gastric Cancer
ACTIVE_NOT_RECRUITING
NCT04784715
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
1,157
Enrollment(s)
283
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer; HER2-positive; Metastatic
COMPLETED
NCT04471870
ARCANGELO (itAlian pRospective Study on CANGrELOr)
1,005
Enrollment(s)
30
Study location(s)
OBSERVATIONAL (None)
Acute Coronary Syndrome
NOT_YET_RECRUITING
NCT07416253
Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer
68
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
RECRUITING
NCT06494111
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
295
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Lymphedema
Fibrosis
11
12
13
14
15